Migraine headaches: Implications for management from a nationwide patient survey

Headache Quarterly

Volumn 11, Issue 2, 2000, Pages 105-112

  Adelman, J U ^a   Von Seggern, R L ^a   Mannix, L K ^a  

^a Headache Wellness Center   (United States)

Author keywords

Consulters; Headache survey; Migraine demographics

Indexed keywords

ACETYLSALICYLIC ACID; ANTIMIGRAINE AGENT; BUTALBITAL; CAFFEINE; DEXTROPROPOXYPHENE; DEXTROPROPOXYPHENE NAPSILATE; DICHLORALPHENAZONE; ELETRIPTAN; ERGOTAMINE; ESGIC; FLORINAL; ISOMETHEPTENE MUCATE; NARATRIPTAN; NARCOTIC ANALGESIC AGENT; PARACETAMOL; PHRENILIN; RIZATRIPTAN; SUMATRIPTAN; SUMATRIPTAN SUCCINATE; WIGRAINE; ZOLMITRIPTAN;

ADOLESCENT; ADULT; ARTICLE; CHRONIC PAIN; DRUG INDUCED DISEASE; HEADACHE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE; PATIENT SATISFACTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033838480     PISSN: 10597565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Prevalence of migraine headache in the United States
2. Classic migraine. A prospective recording of symptoms
3. Genetic epidemiology of migraine
4. Migraine in the United States: A review of epidemiology and health care use
5. Undiagnosed migraine headaches: A comparison of symptom-based and reported physician diagnosis
6. Healthcare resource and lost labor costs of migraine headache in the U.S.
7. Impact of migraine in the United States: Data from the National Health Interview Survey
8. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
9. Measuring the functional status and well-being of patients with migraine headache
10. Transformed or evolutive migraine
11. Chronic daily headache: Long-term prognosis following inpatient treatment with repetitive IV DHE